Mutations in. the p53 gene are common in lung cancer. Using data from the the International Agency for Research on Cancer p53 mutation database (R1), we. have analyzed the distribution and nature ofp53 mutations in 876 lung tumors described in the literature. These analy confirm that G to T transitions are the predominant pe ofp53 muton in lug cancer from smokers. The most frequendy. mutato. codons indude 157, 158, 179,-248, 249, and 273, and several of them (157, 248, and 273) 
exposure to PAHs, and lung cancer. They aso indicate that a de pattern of mutations occurs in nonsmokers, and this obsevation may help to identify other agents causally involved in lung.cancer in nonsmokers. Key wonr. benz(a)pyrene, lung cancer, nonsmokers, p53 mutations, tobac'co. Environ HealthPpce106:385-391 (1998) . [Oline 10june 1998] hatp://ehpnetl.nies.nih.gov/ldosa998/106p385-391h~aand&/abstract.html Lung cancer is the leading cause of death in developed countries and is considered as one of the most common cancers worldwide (1) (2) (3) . Tobacco smoking has been identified as a major risk factor for the development of this cancer (4) (5) (6) . Overall, recent cohort studies show that the risk of death from lung cancer in smokers of two or more packs of cigarettes per day is about 20 times that of nonsmokers (5, 6) . Tobacco smoke is a complex mixture that contains about 3,800 different potentially harmful chemicals (7) . Several of these chemicals are proven carcinogens and occur at significant concentrations in tobacco smoke. These chemicals include benzo(a)pyrene [BaP, a polycyclic aromatic hydrocarbon (PAH)] at 20-40 ng/cigarette, N-nitroso compounds at up to 200-3,000 ng/cigarette, 4-aminobiphenyl (an aromatic amine) at 2.4-4.6 ng/cigarette, and vinyl chloride at 1.3-16 ng/cigarette (8, 9) . The exact contribution of each of these various carcinogens to lung cancer induced by tobacco smoke is poorly understood.
Deletion and point mutations in the p53 tumor suppressor gene are common in most types of human cancers, including lung cancer. Missense mutations occur at about 300 distinct positions within the p53 coding sequence. The diversity of positions and chemical natures of these mutations allows the determination of tumor-specific mutation spectra that can provide clues to the nature of the mutagenic agents which are involved as causative agents (10) (11) (12) . To facilitate the analysis and interpretation of these mutations, a databjse of p53 mutations in human tumors and cell lines is maintained at the International Agency of Research on Cancer (IARC). This database, initiated in 1991 by Hollstein et al. (13) , is exclusively based on published material and contains about 8,000 somatic mutations in an electronic format (14) .
To determine whether the spectrum of p53 mutations may aid in understanding the role of carcinogens associated with tobacco smoke, we have carried out detailed analyses of the mutations associated with lung cancer compiled in the IARC p53 mutation database (849 cases). We have reviewed these data in the light of recent progress in our understanding of the mechanisms of 1) selective adduct formation in the p53 coding sequence, 2) strandspecific and position-specific DNA repair, and 3) selection of mutant proteins with specific functional properties. Our analyses confirm and extend previous reports that G to T transversions are specifically found in tumors from smokers (11 analysis of the database, we developed a program using FileMaker Pro 3.0 (Claris Corporation, Santa Clara, CA) that is described on our database web site and published elsewhere (14) . The database contains information on 876 mutations in lung tumors. These mutations were compared with those found in breast tumors (729 cases) and colon tumors (900 cases) because they occur at high frequencies in the general population, they frequently contain p53 mutations [approximately 50% in colon cancer (11) , and 15-40% in breast cancer (15) ], and they are well represented in the LARC p53 database.
The database is based on published records and does not contain information on tumors without p53 mutations. When information was provided on the smoking status of individual patients with lung cancer, the tumors were classified into two groups: ever smoked (236 cases) and never smoked (36 cases 
Results
High frequency of G to T transversions. In lung cancer, p53 missense mutations are detected in about 60% of the tumors, and about one-third of these mutations have been reported as G to T transversions (11) . Figure  1 slower repair kinetics than those formed on the transcribed strand (20, 21) . Repair efficiency could thus contribute strongly to the p53 mutation spectra in lung cancer. The high prevalence of G to T transversions, as well as the strand bias in the distribution of these mutations, is highly suggestive of the involvement of exogenous carcinogens as direct mutagens (11, 22) . In experimental systems and in several cancers other than lung, G to T transversions have been shown to result from the mutagenic effect of several distinct classes of agents including PAHs, aromatic amines, mycotoxins such as aflatoxin B,, ionizing radiation, and oxidants (11, 23, 24) . G to T transversions are also minor mutations caused by some Nnitroso compounds such as 4-(methylnitrosamino)-1-(3-pyridyl)-1 -butanone (NNK) (25) (27) found 29% of G to T transversions in SCC and 46% in ADC. Both studies suggested that G to T transversions were more common in ADC than in SCC. Analysis of the IARC p53 mutation database, however, reveals a reverse trend (Fig. 2) . ADC is considered to be less strongly associated with smoking than SCC or SCLC, and ADC has a higher prevalence than SCC or SCLC among nonsmokers (28, 29 Guinee et al. (38) and Kure et al. (26) have reported a higher frequency of G to T transversions in women than in men; both of these observations were based on a small number of cases and were not significantly different. In the IARC p53 mutation database, information exists on 81 men and 32 women with p53 mutations in lung tumors. Figure 7 shows that in our analyses we also find that women have a higher frequency of G to T mutations and men a higher frequency of G to A mutations at non-CpG sites, although these spectra are not significantly different. This coincides with the evidence that women are more susceptible to DNA damage from cigarette smoke and other carcinogens (39) . However, the numbers analyzed are still relatively small, and larger study groups are needed to draw any definite conclusions of p53 mutations in men and women.
Conclusions
Carcinogens damage DNA in specific ways, and in various circumstances their fingerprints can be found in the mutations found in DNA of cancer patients. DNA repair and bioselection of mutants with particular properties can also contribute to the final spectrum of mutations observed in any particular type ofcancer. The extent of DNA damage is influenced by genetic susceptibility factors, induding the capacity to metabolize carcinogens in exposed individuals (40) . The analysis ofdata on p53 mutations in lung cancer from the IARC p53 database allows a better definition of the contribution of these three types of factors to the mutation spectrum in tumors associated with tobacco consumption.
This analysis confirms that G to T transversions are frequent in lung cancer from smokers, but not in nonsmokers. This suggests that G to T transversions are a molecular signature of mutagenesis by tobacco smoke.
Although many carcinogens from tobacco smoke may induce such mutations, the evidence suggests that one major class of causative agents is PAHs, in particular BaP. First, G to T transversions are consistently found in a number of experimental model systems after exposure to either tobacco smoke or BaP, such as in Salmoned, where 80% of the mutations induced by cigarette smoke are G to T transversions (41) , in human, hamster, and mouse diploid cells (42, 43) , and in mouse skin (22) . Second, many of these mutations occur at bases in codons 157, 248, and 273, which are strong and specific sites for adduct formation by metabolites of BaP in cultured cells (25, 30) . These codons contain CpG repeats. Recent evidence indicates the presence of 5-methylcytosine in CpG sequences may strongly enhance the formation of BPDE-DNA adducts at the G position (31) .
Upon absorption by target cells, BaP requires metabolic activation by CYP2E1 to generate compounds that form promutagenic DNA adducts. The most significant metabolite is BPDE which preferentially binds covalendy on the N2 position of guanine (44) . Promutagenic BPDE-DNA adducts are detectable in nontumorous and tumorous lung tissue from smokers (7,26, 45-44). Furthermore, an association between Figure 6 .
In a recent paper, Gao 14 mutations, an unusual phenomenon that has no equivalent in the IARC p53 mutation database. On the basis of their results, the authors concluded that there is no difference in the frequency of G to T transversions between smokers and nonsmokers. We consider that these data should be taken cautiously, as they may reflect either a very peculiar population or be the result of laboratory artifacts.
The molecular basis of the mutation spectrum in nonsmokers is unknown. Epidemiological studies have pointed to roles of passive smoking, environmental radiation, and occupational exposure to metals (29, 51, 52 (11) .
In summary, these analyses show that p53 mutations in lung cancer from smokers carry highly significant fingerprints of exposure to tobacco smoke components, in particular BaP. These fingerprints are not found in nonsmokers, which therefore leaves open the possibility that distinct tobacco or environmental carcinogens may also play an important role in the etiopathology of lung cancer.
